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Introduction 
Atopic dermatitis (AD, atopic eczema) is 
an inflammatory, chronic and recurrent 
dermatosis, whose dominant symptom is 
persistent and severe pruritus. Skin changes 
usually appear in early childhood, favoring 
typical locations and having a characteristic 
appearance (Leung & Bieber 2003). Living 
conditions and children maturation in the 
developed countries have fundamentally 
changed over the past years. The differences 
include frequency of infectious diseases, their 
treatment, contact with microorganisms, diet, 
chemical composition and pollution of air, all 
of which are connected with the constantly 
increasing incidence of allergies, especially in 
childhood and youth. The prevalence of 
atopic dermatitis has doubled or tripled in the 
industrialised countries over the past three 
decades; 15% to 30% of children and 2% to 
10% of adults are currently affected by the 
illness (Williams & Flohr 2006). Atopic 
dermatitis is among the most frequently 
appearing skin diseases and is capable of 
coexisting with other IgE dependent atopic 
illnesses, e.g. with bronchial asthma, rash, 
allergic catarrh of the upper respiratory tract 
and nutritional allergy (Jansen et al. 1973). 
Type I (allergy) of hypersensitivity are the 
underlying reason for these illnesses. They 
represent a special kind of reaction of the 
organism. Sometimes a disproportionately 
small dose of antigen triggers dramatic 
manifestations (Custovic & Simpson 2012). 
The etiopathogenesis of AD is complex  
and still unexplained; immunologic, 
environmental and genetic factors are 
involved, and should be considered in the 
context of genes encoding structural and 
functional proteins of the epidermis and main 
elements of the immune system (Bieber 
2008). The international HapMap project was 
started in 2002 to develop a public database 
that could help researchers find genes 
associated with human diseases and 
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 ABSTRACT 
The pathogenesis of atopic dermatitis (AD) is a very complicated process that involves 
an intricate array of molecules. Nowadays it is generally accepted that cytokines play 
an important role in the progression of the clinical presentation of atopic dermatitis. 
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individual responses to pharmacological 
agents (http:hapmap.ncbi.nlm.nih.gov). Also, 
genome-wide association studies (GWAS) 
investigate the relationship between disease 
and common genetic variants spread across 
the genome (McCarthy et al. 2008). Meta-
analyses have enabled researchers to 
distinguish loci of susceptibility to atopic 
dermatitis located on ten different 
chromosomes: 1, 2, 3, 5, 6, 7, 10, 11, 19, 20. 
In European populations, the loci 4q27, 5q31,  
 
11p13, 11q13, 16p13.13, 17q21.32 and 
19p13.2 were identified (Tamari et al. 2013; 
Ellinghaus et al. 2013). At present the 
attention of researchers is focused on seeking 
genes whose mutations or specific allelic 
forms predispose organisms to development 
of AD. Identification of genetic 
polymorphisms due to single nucleotide 
polymorphisms (SNPs) is the most common 
approach for finding genetic factors 
conditioning susceptibility to disease.
Genetic factors that influence development of the AD phenotype 
Role of the skin barrier 
Defects of the skin barrier, which 
physiologically constitutes the natural 
protection of the organism, are clearly 
associated with the disease phenotype 
(Boguniewicz & Leung 2011). The cornified 
envelope is the most important layer of 
epidermis due to the protection it from 
physical injuries and exogenous compounds. 
It consists of a number of dead, completely 
cornified cell layers. These cells are quite 
elastic, which helps them to fulfill their 
function. The cornified layer is hydrophobic 
thus, protects the skin against penetration of 
water from the environment and prevents 
dehydration of the organism (Alasdair et al. 
1994). The cornified envelope consists of 
specialized proteins: loricrin (LOR), small 
proline-rich proteins (SPRR), a family of 
fused-type S100 proteins composed of 
filaggrin (FLG), repetin (RPTN), cornulin 
(CRNN), hornein (HRNR), and late cornified 
envelope-like proline-rich 1 (LELP1). Genes 
encoding these proteins are found within the 
epidermal differentiation complex (EDC), a 
gene cluster whose products are responsible 
for the final diversification of keratinocytes 
(Kypriotou et al. 2012). These proteins form a 
thick layer resistant to physical and chemical 
factors, influence production of natural 
moisturizing compound and ensure the 
appropriate pH of the skin, that prevents the 
penetration of infectious factors to its deeper 
layers. However, in AD patients, more rapid 
desquamation of the cornified layer occurs 
accompanied by exaggerated degradation of 
ceramides, which results in increased loss of  
 
water and increased permeability to 
exogenous allergens. This is frequently 
followed by the development of inflammation 
(Proksch et al. 2006). Moreover, reduced 
level of antimicrobial factors in the epidermis 
frequently results in recurrent bacterial 
infections in affected individuals (Bieber 
2008). Therefore, genetic alterations including 
polymorphisms and mutations in genes 
encoding the proteins involved in the proper 
building of the epidermal barrier, may carry a 
certain degree of risk of the appearance of 
atopic dermatitis; this at present is being 
intensively studied.  
Recent results of scientists from the 
University of Dundee provide a breakthrough 
in the area of AD genetics by revealing that 
FLG null alleles are a frequent transmissible 
predisposing factors in common atopic 
dermatitis. This study documented that 
inherited reduction or loss of filaggrin 
expression is a major predisposing factor in 
AD, and provided a molecular mechanism to 
define the coexistence of a clinical subtype of 
asthma (Palmer et al. 2006). These results 
initiated a flurry of research on this protein. 
Filaggrin functioning rely on binding of 
keratin fibers in the process of keratinocytes 
maturation. As a result of FLG conversion, a 
natural moisturizing factor is produced (Gan 
& McBride 1990). The metabolism of this 
protein result in an acidic pH generation in the 
cornified layer, an optimal environment for 
the enzymes synthesizing lipids of the 
cornified envelope (CE) (Markova et al. 
1993).  
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R501X and 2282del4 are the most 
frequently occurring mutations of FLG. It was 
demonstrated that lack of FLG expression or 
its decrease in the skin caused by gene 
mutation occurs mainly in patients with early 
onset of the disease, a severe course of AD 
and elevated IgE levels (Palmer et al. 2006). 
It must be emphasized that FLG mutations 
occur only in a portion of AD patients. 
Moreover, in 9% of the European population, 
despite observed mutations, the atopic 
dermatitis phenotype was not developed. 
These results indicate the possible 
significance of polymorphisms and mutation 
within other than FLG genes encoding 
proteins of the epidermal differentiation 
complex (EDC) in the development of AD.  
Loricrin is a major protein component of 
the cornified cell envelope found in terminally 
differentiated epidermal cells. It is a glycine-
serine-cysteine-rich protein, synthesised in the 
granular (stratum granulosum) layer (Hohl et 
al. 1991). A connection between abnormal 
expression of LOR and skin diseases has been 
proven. Data has shown that mutation 
730insG in LOR, which elongates loricrin by 
22 amino acids due to delayed termination, is 
a factor in honeycomb palmoplantar 
keratoderma and the diffuse-ichthyosis form 
of dermatosis (Gedicke et al. 2005). Another 
study found that the down-regulation of 
loricrin and filaggrin was accompanied by up-
regulation of some keratins in active AD skin 
lesions. The authors suggest that deterioration 
of epidermal differentiation associated with 
altered expression of genes located on 1q21 
might be a key abnormality in atopic 
dermatitis (Weldinger et al. 2013).  
The next gene to be identified as a possible 
factor in the development of AD is LELP-1. 
This gene encodes a late cornified envelope-
like prolin-rich protein. Indian scientists 
found a significant link between rs7534334 
SNP and log10 serum IgE levels in the group 
of patients (Sharma et al. 2007). However, 
this was only a single study and the authors 
stressed the need for further research.  
A single nucleotide polymorphism within 
the gene encoding hornerin has recently been 
linked with susceptibility to atopic dermatitis 
(Henry et al. 2011). In the epidermis, hornerin 
was found to be co-localised with profilaggrin 
in keratohyalin granules in cells of the 
granular layer. These findings indicate that 
hornerin has a function similar to or mutually 
complementary to profilaggrin in the 
cornifying epithelium (Makino et al. 2001). 
Human protein hornerin was detected in 
regenerating skin following a wound and in 
psoriatic skin (Takaishi et al. 2012). It has 
been reported that allele C of rs877776 in 
HRNR gene is a risk factor of increased 
frequency of AD compared to controls even 
following exclusion of FLG mutation carriers 
(Esparza-Gordillo et al. 2009). In an Austrian 
population, single nucleotide polymorphisms, 
rs7927894 on chromosome 11q13.5 within 
the region of the HRNR gene, was identified 
as novel susceptibility variant for atopic 
dermatitis (Greisenegger et al. 2013). This 
study point to the statistically significant 
association of the rs7927894 variant with AD, 
but not with other disease-related phenotypes. 
Therefore, authors of that study postulated 
that the rs7927894 single nucleotide 
polymorphism selectively influences eczema 
development. 
Repetin, a protein consisting of 784 amino 
acids, has a structure resembling the helix-
calcium-binding-loop-helix domain of 
parvalbumin, hands of the S100 type and 
internal tandem repeats typical for CE 
precursor proteins (Huber et al. 2005). This 
protein associates with keratin intermediate 
filaments and is partially cross-linked to the 
cell envelope (Krieg et al. 1997). It has been 
proposed that this protein may be a marker of 
disturbances in differentiation of skin barrier 
cells and may be significant in the 
development of atopic dermatitis. 
Polymorphism and mutations in the CRNR 
gene may also be associated with AD. Data 
has shown that human cornulin mRNA is 
expressed primarily in the upper layers of 
differentiated squamous tissues including the 
epidermis (Contzler et al. 2005). Data 
concerning eczema in Swedish families has 
shown that the CRNN polymorphism 
rs941934 is significantly associated with 
atopic eczema in the genetic analysis, 
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although only as part of an extended 
haplotype including a known associated 
variant 2282del4 in the filaggrin gene (Liedén 
et al. 2009).  
The epidermal differentiation complex 
genes also encode the precursor protein of the 
cornified cell envelope, such as small proline-
rich proteins (Hohl et al. 1995). The SPRR 
gene class consists of two SPRR1 and seven 
SPRR2 genes, along with a single SPRR3 
gene (Kartasova & van de Putte 1988). In 
human cornea tissue, the expression of 
SPRR1, SPRR2 and filaggrin protein were 
detected in the central and peripheral corneal 
and limbal epithelium (Tong et al. 2006). 
Cabral et al. noticed that the structural 
organization and regulation of the SPRR gene 
family reflects the epithelial barrier’s role i.e. 
guarantee optimal protection to the organism 
(Cabral et al. 2001). Nomura et al. recently 
reported that SPRR2C, a component of the 
CE with a protective skin barrier function, 
showed the largest (eleven-fold) increase in 
psoriatic skin lesions as compared with AD 
(Nomura et al. 2003). Polish investigators 
noticed the deregulated increase in SPRR 
expression in chronic atopic skin lesions; 
SPRR1A and SPRR2C lose their coexpression 
with S100 genes and other 1q21 transcripts 
(Jarzab et al. 2009). They hypothesize that 
this altered pattern reflects an insufficient rise 
in SPRR expression, which is unable to 
compensate for the lack of loricrin and thus 
contributes to the persistence of chronic AD 
skin changes.  
The correlation of gene polymorphism 
with atopic disease was also observed. The 
data suggested a dominant mode of 
inheritance for the risk allele of SPRR3 in 
eczema (Marenholz et al. 2011). In this study 
the frequency of appearance of the gene 
polymorphism rs28989168 among the AD 
patients and control group was analyzed. It 
appeared that the SPRR3 variant associated 
with atopic dermatitis carried an extra 24-bp 
repeat in the central domain, which may alter 
the physical properties of the CE (Marenholz 
et al. 2011). 
To sum up, among EDC genes several 
genes have been identified as factors 
contributing to the risk of AD development. 
This point the need of further research 
particularly since the present results have not 
been confirmed by independent laboratories 
and are mostly incomplete. More 
investigations involving distinct study 
populations are needed to assess the role of 
identified polymorphisms in atopic dermatitis. 
Identification of the genes that are deregulated 
in the atopic organism is thus likely to 
improve our understanding of AD 
pathogenesis [Tab.1].  
 
Role of interleukins 
Interleukins are molecules that regulate 
diverse processes, e.g. the proliferation, 
differentiation and mobility of cells. Acting 
on many cells, interleukins are mediators of 
inflammatory responses and immunologic 
processes. Also, keratinocytes, in response to 
barrier dysfunction, produce a variety of 
cytokines (Kayserova et al. 2012, Maeve et 
al. 2013). Therefore, investigators are also 
focused on examining genes encoding 
interleukins, which may play a role in 
development and progression of AD.  
Interleukin 4 (IL-4) is produced through 
stimulation Th lymphocytes by an antigen. A 
correlation exists between IL-4 secretion and 
IgE concentration in plasma; its increased 
expression causes inflammatory responses of 
an allergic character (Namkung et al. 2011a). 
Czech investigators analyzed polymorphism 
in IL-4 receptor α (IL-4Rα) at position +1902 
in patients with AD and a control group. This 
work showed a significant association 
between the genotypes of IL-4Rα and an 
increased level of tree-pollen-specific IgE 
(Kayserova et al. 2012).  
The initial finding that interleukin-7 (IL-7) 
is produced by human keratinocytes 
suggested its possible involvement in skin 
diseases. A polymorphism T244I of receptor 
IL-7R was also found to increase the risk of 
AD in a group of German patients (Hoffjan et 
al. 2010). 
Interleukin 9 (IL-9) is produced by 
stimulated T-lymphocytes, particulary Th2. 
This cytokine plays an important role in the 
regulation of antiparasitic response. It has 
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been suggests that SNP rs31563, located 
within the IL-9 gene, is associated with 
increased susceptibility to AD (Namkung et 
al. 2011b). Similarly, rs3093467 SNP in the 
IL-9R gene seems to be associated with an 
increased risk of developing non-allergic AD 
(Namkung et al. 2011b). 
Interleukin 12 and 13 (IL-12 and IL-13) 
are other cytokines that may play a critical 
role in AD. IL-12 is produced by antigen-
presenting cells. It can also be secreted by 
keratinocytes (Namkung et al. 2010). IL-13 is 
similar in its action to IL-4, and receptors for 
these two cytokines share a common subunit 
(Hussein et al. 2011). Single nucleotide 
polymorphisms in IL-4 and IL-13 have been 
reported in patients with allergic diseases. 
Korean researchers noticed that two SNPs, 
rs3091307 and rs20541, from the IL-13 gene 
showed a significant difference in allelic or 
genotypic distributions between AD and 
normal groups. However, they did not observe 
any associations for the IL-4Rα polymorphism 
C3223T or the IL-4 polymorphism C590T 
(Namkung et al. 2011a).  
 
TABLE 1. Genes with polymorphism and mutation linked to AD risk. 
protein gene SNP/mutation Allel 
1 
Allel 
2 
Chromosome 
loci 
Functional 
group 
Interleukin 9 IL-9 rs31563 C T 5:135235606 cytokine- 
related 
Interleukin 7 
receptor alpha chain 
IL-7R rs11567705 C G 5:35861152 cytokine -
related 
Interleukin 13 IL-13 rs3091307 A G 5:131989136 cytokine -
related 
Interleukin 13 IL-13 rs20541 A G 
 
5:131995964 cytokine -
related 
Interleukin 18 IL-18 rs360721 C G 11:112025916 cytokine -
related 
Filaggrin FLG R501X C T 1:152285861 skin barrier 
Hornerin HRNR rs877776 C G 1:152178018 skin barrier 
Cornulin CRNR rs941934 C T 1:152390452 skin barrier 
Late cornified 
envelope-like 
proline-rich 1 
LELP-
1 
rs7534334 C T 1:153177852 skin barrier 
 
Interleukin 10 (IL-10) fulfils many 
functions which result in suppression of 
immune response on a cellular level and 
inflammatory response (Lacy et al. 2009). 
Examinations conducted among children 
under the age of 3 years have shown the 
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potential role of IL10 SNPs in the 
development of immune-mediated diseases, 
such as AD (Raedler et al. 2013).  
Keratinocytes and epithelial cells can secrete 
interleukin 18 (IL-18). Genome – wide 
association study suggested IL-18R1 role for 
interleukins signaling (Hirota et al. 2012). 
Ibrahim et al. noticed that the -140 GG 
genotype and the -140 G allele were more 
often observed in patients with severe AD 
compared with mild and moderate phenotypes 
(Ibrahim et al. 2012). 
Interleukin 31 (IL-31), produced by Th2 
lymphocytes, acts on macrophages and 
keratinocytes. In these cells there is a receptor 
for this cytokine (Kasraie et al. 2013). It is 
postulated that IL-31 plays a role in AD 
pathogenesis. Associations between IL-31 
gene variants and eczema have previously 
been demonstrated in three independent 
European populations (Schulz et al. 2007). 
The data accumulated to day indicate that the 
level of expression of genes encoding 
interleukins has a critical influence on the 
developing atopic dermatitis. Interleukins 
SNPs status of the organism can have great 
meaning if we want predict risk of allergy 
[Tab.1].  
 
Conclusion
Atopic dermatitis is a multifactorial-
disease. The data we presently have at our 
disposal show that there is no simple 
correlation associated with a single gene 
defect or with the occurrence of its 
determined allelic form and the risk of 
contracting the disease. It seems that the 
interaction of many genes plays a role in the 
progression of the disease. Moreover their 
expression is influenced by environmental 
factors. All authors emphasize the need to 
conduct intensive research to clarify the 
genetic basis of AD. 
Determination whether a link exists 
between the frequency of appearance of the 
particular variant of the polymorphic gene 
coding protein s forming the cornified 
envelope or specific interleukins, on one 
hand, and the risk of atopic dermatitis on the 
other, will help us to better understand the 
pathogenesis of this disorder. This will 
influence the direction of research on new 
therapeutic methods and enable the 
development of a more effective and safer 
treatment for atopic dermatitis.  
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